v3.26.1
Condensed Consolidated Balance Sheet (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash, cash equivalents and current restricted cash $ 300,761 $ 369,074
Accounts receivable, net 81,886 90,255
Inventory, net 61,851 65,823
Other current assets and prepaid expenses 55,738 56,729
Total current assets 500,236 581,881
Property, plant and equipment, net 71,454 73,926
Intangible assets, net 477,566 516,276
In-process research and development 195,000 195,000
Goodwill 481,515 484,289
Investments 40,217 14,168
Operating lease right-of-use assets 43,971 46,930
Other assets 19,494 19,474
Total assets 1,829,453 1,931,944
Current liabilities:    
Accounts payable 50,043 41,103
Accrued expenses 77,757 84,406
Current maturities of operating leases 11,009 10,917
Current portion of lines of credit and notes payable 10,558 10,251
Total current liabilities 149,367 146,677
Operating lease liabilities 33,980 36,815
Long term portion of convertible notes 89,857 85,020
Senior secured royalty financing 246,854 246,433
Deferred tax liabilities 108,230 126,241
Other long-term liabilities 16,999 22,799
Total long-term liabilities 495,920 517,308
Total liabilities 645,287 663,985
Equity:    
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 776,128,402 and 789,917,433 shares issued at June 30, 2026 and December 31, 2025, respectively 7,762 7,900
Treasury Stock - 30,174,907, and 30,849,907 shares at June 30, 2026 and December 31, 2025, respectively (2,363) (3,176)
Additional paid-in capital 3,561,114 3,574,942
Accumulated other comprehensive loss (28,393) (21,017)
Accumulated deficit (2,353,954) (2,290,690)
Total shareholders’ equity 1,184,166 1,267,959
Total liabilities and equity $ 1,829,453 $ 1,931,944